Visualizing biomolecules within living microglia in complex environments using a clickable small fluorogenic compound

Wonju Kim,Beomsue Kim,Young-Tae Chang,Yeongran Hwang,Xiao Liu,Minkyo Jung,Ji-Young Mun,Srikanta Sahu

DOI: https://doi.org/10.26434/chemrxiv-2024-kq3lz

2024-11-15

Abstract:Microglia, which are the brain's resident macrophages, have received considerable attention as the leading player in the progression of neurodegenerative disease. However, there are currently no tools available for the tracking of biomolecules within microglia in diverse brain environments. In this study, we developed a multipotent microglial fluorescent probe called CDr20-CO1 that can be regarded as a toolbox for fluorescent labeling of live microglia’s intracellular biomolecules, from in vitro to in vivo. The compound CDr20-CO1 has a dual role namely as a binder for bioconjugation to an azido compound and as a microglia labeler by its specific fluorescent substrate activity for the UGT1A7C enzyme. It visualizes microglial lysosome, choline, or newly synthesized protein in the live heterogeneous brain cell culture condition by sequentially treating CDr20-CO1 following the addition of a binding partner such as morpholine-azide, choline-azide, or L-azidohomoalanine. This allows observing the low responsiveness of lysosomal fusion and choline metabolism of microglia in contrast to neuroinflammatory stimuli comparing coexistence with other glial cells against isolated microglia to see how they are different. Eventually, the labeling system works even in intact live mouse embryos, suggesting the application extends up to the microglia's organelles/biomolecules in vivo. A new approach for tracking microglial organelles/biomolecules using CDr20-CO1 will be a potent tool for deciphering microglia’s pathophysiological role in real-time.

Chemistry

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to track biomolecules in microglia in a complex brain environment. Specifically, there is currently a lack of effective tools to track biomolecules in microglia under different brain environmental conditions, especially in vivo conditions. As resident macrophages in the brain, microglia play a crucial role in the development of neurodegenerative diseases. However, existing research methods often rely on purified primary microglia, and these cells will quickly lose their characteristics after being removed from their natural brain microenvironment, which may lead to a misunderstanding of the physiological functions of microglia.

To this end, the authors developed a versatile microglia fluorescence probe - CDr20 - CO1, which can be used to label organelles or biomolecules in living microglia, and can be applied from in vitro to in vivo. CDr20 - CO1 has a dual role: on the one hand, it can be bioconjugated with azide compounds; on the other hand, it achieves selective labeling of microglia through the activity of a specific fluorescent substrate against the UGT1A7C enzyme. By sequentially treating CDr20 - CO1 and its binding partners (such as morpholine azide, choline azide or L - azido - homoproline), the lysosomes, choline or newly synthesized proteins in microglia can be observed under complex brain cell culture conditions. This not only helps to observe the hyporesponsiveness of microglia under neuroinflammatory stimulation, but also enables comparison of the differences between microglia when co - existing with other glial cells and in an isolated state. In addition, this labeling system can even work in intact living mouse embryos, indicating that its application range can be extended to organelles/biomolecules in microglia in vivo. In conclusion, the new method using CDr20 - CO1 will become a powerful tool for real - time analysis of the pathophysiological role of microglia.